JP2011518619A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518619A5
JP2011518619A5 JP2011506464A JP2011506464A JP2011518619A5 JP 2011518619 A5 JP2011518619 A5 JP 2011518619A5 JP 2011506464 A JP2011506464 A JP 2011506464A JP 2011506464 A JP2011506464 A JP 2011506464A JP 2011518619 A5 JP2011518619 A5 JP 2011518619A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
component
composition according
minutes
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011506464A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518619A (ja
JP5711113B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/041590 external-priority patent/WO2009132226A1/en
Publication of JP2011518619A publication Critical patent/JP2011518619A/ja
Publication of JP2011518619A5 publication Critical patent/JP2011518619A5/ja
Application granted granted Critical
Publication of JP5711113B2 publication Critical patent/JP5711113B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011506464A 2008-04-24 2009-04-23 チオール化キトサンゲル Active JP5711113B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4759008P 2008-04-24 2008-04-24
US61/047,590 2008-04-24
US5503708P 2008-05-21 2008-05-21
US61/055,037 2008-05-21
PCT/US2009/041590 WO2009132226A1 (en) 2008-04-24 2009-04-23 Thiolated chitosan gel

Publications (3)

Publication Number Publication Date
JP2011518619A JP2011518619A (ja) 2011-06-30
JP2011518619A5 true JP2011518619A5 (cg-RX-API-DMAC10.html) 2012-05-31
JP5711113B2 JP5711113B2 (ja) 2015-04-30

Family

ID=40745190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011506464A Active JP5711113B2 (ja) 2008-04-24 2009-04-23 チオール化キトサンゲル

Country Status (7)

Country Link
US (1) US20090269417A1 (cg-RX-API-DMAC10.html)
EP (1) EP2313104B2 (cg-RX-API-DMAC10.html)
JP (1) JP5711113B2 (cg-RX-API-DMAC10.html)
CN (1) CN102159220A (cg-RX-API-DMAC10.html)
AU (1) AU2009240511B2 (cg-RX-API-DMAC10.html)
CA (1) CA2721985C (cg-RX-API-DMAC10.html)
WO (1) WO2009132226A1 (cg-RX-API-DMAC10.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102399295B (zh) * 2010-09-09 2013-11-06 常州百瑞吉生物医药有限公司 低巯基化改性度生物相容高分子巯基化衍生物及其交联材料和用途
US9486190B2 (en) 2011-10-28 2016-11-08 Medtronic Xomed, Inc. Spray delivery system
US10441959B2 (en) * 2011-10-28 2019-10-15 Medtronic Xomed, Inc. Multi-orifice spray head
US9987391B2 (en) 2013-03-13 2018-06-05 St. Jude Medical Coordination Center Bvba Injectable hydrogels
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9480828B2 (en) 2013-11-14 2016-11-01 Gyrus Acmi, Inc. Treatment method for the inferior turbinate
EP3139903B1 (en) 2014-05-07 2019-07-03 Croma-Pharma Gesellschaft m.b.H. Aqueous ophthalmic solution and method for treating dry eye syndrome
PL3368006T3 (pl) 2015-10-30 2020-06-01 Croma-Pharma Gesellschaft M.B.H. Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego
CN108348455B (zh) 2015-10-30 2021-04-09 克罗马药品股份有限公司 无菌水性眼用溶液的治疗用途
CN107684550B (zh) * 2016-08-03 2020-04-10 徐天宏 糖尿病治疗产品及其制备与应用
CN107684551A (zh) * 2016-08-03 2018-02-13 徐天宏 糖尿病或肥胖疾病治疗产品及其制备与应用
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
JP7339267B2 (ja) * 2017-11-07 2023-09-05 ロイヤル カレッジ オブ サージョンズ イン アイルランド 固形腫瘍癌の治療としての腫瘍内投与のための熱応答性ヒドロゲル
CN112334167A (zh) 2018-06-15 2021-02-05 克罗马药品有限责任公司 包含交联聚合物的水凝胶组合物
BR112020024654B1 (pt) 2018-06-15 2024-02-27 Croma-Pharma Gmbh Composição de hidrogel estéril, unidade de aplicação para injeção,seus usos, método cosmético, enchimento de tecido mole, e implante ou depósito
WO2021123247A1 (en) 2019-12-19 2021-06-24 Croma-Pharma Gmbh Thiol-modified hyaluronan and hydrogel comprising the crosslinked hyaluronan

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184385A (en) * 1961-10-16 1965-05-18 Eastman Kodak Co Dry, vitamin-active product and process for preparing same
US3989044A (en) * 1975-08-11 1976-11-02 Warner-Lambert Company Syringe
EP0112852B1 (en) * 1982-06-24 1988-06-08 SMITH, Robert Alan Pharmaceutical gel composition
JPS62123112A (ja) * 1985-11-22 1987-06-04 Sunstar Inc 軟膏基剤
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5308546A (en) * 1991-12-09 1994-05-03 Glow-Tec Phosphorescent toy gel composition and methods of manufacture
US5550189A (en) * 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
GB2276819B (en) * 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
US5622834A (en) * 1993-12-01 1997-04-22 Marine Polymer Technologies, Inc. Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture
WO1997022371A1 (en) * 1995-12-18 1997-06-26 Collagen Corporation Crosslinked polymer compositions and methods for their use
IL118376A0 (en) * 1996-05-22 1996-09-12 Univ Ben Gurion Polysaccharide sponges for cell culture and transplantation
US20050096282A1 (en) * 1997-04-21 2005-05-05 Lewin Alfred S. Adeno-associated virus-delivered ribozyme compositions and methods for the treatment of retinal diseases
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
DE10035799A1 (de) * 2000-07-22 2002-01-31 Kalle Nalo Gmbh & Co Kg Nach dem Aminoxidverfahren hergestellte Nahrungsmittelhüllen auf Cellulosebasis
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
EP1392182A1 (en) * 2001-05-04 2004-03-03 Concentric Medical Hydrogel vaso-occlusive device
US20060004314A1 (en) * 2001-06-14 2006-01-05 Hemcon, Inc. Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
ATA13842001A (de) * 2001-08-31 2002-10-15 Mucobiomer Biotechnologische F Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung
DE10152407A1 (de) * 2001-10-24 2003-05-08 Aesculap Ag & Co Kg Zusammensetzung aus mindestens zwei biokompatiblen chemisch vernetzbaren Komponenten
US6664301B1 (en) * 2002-02-20 2003-12-16 Robert D. Kross Method for using glycol additives to texturally modify natural gum hydrogels
US20050019404A1 (en) * 2003-06-30 2005-01-27 Hsing-Wen Sung Drug-eluting biodegradable stent
GB2393120A (en) * 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
DE10318802A1 (de) * 2003-04-17 2004-11-04 Aesculap Ag & Co. Kg Selbsthaftendes resorbierbares Hämostyptikum
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US8703659B2 (en) * 2005-01-24 2014-04-22 Halliburton Energy Services, Inc. Sealant composition comprising a gel system and a reduced amount of cement for a permeable zone downhole
US7834065B2 (en) * 2005-01-31 2010-11-16 Bmg Incorporated Medical-use two part reactive adhesive and medical-use resin having self-degradation property
WO2006092799A1 (en) * 2005-03-02 2006-09-08 Polyrizon Ltd. Method for removal of toxins from mucosal membranes
TW200719884A (en) * 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
DE102005030011A1 (de) * 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Verfahren zur Herstellung von sterilen Polysaccharidlösungen
US20070031467A1 (en) * 2005-08-04 2007-02-08 Abrahams John M Composition and method for vascular embolization
FR2889449B1 (fr) * 2005-08-05 2011-06-10 Khorionyx Preparations implantables
WO2007071375A1 (en) * 2005-12-22 2007-06-28 Unilever Plc Antiperspirant compositions
US20080069857A1 (en) * 2006-04-12 2008-03-20 Yoon Yeo Compositions And Methods For Inhibiting Adhesions
US20080075657A1 (en) * 2006-04-18 2008-03-27 Abrahams John M Biopolymer system for tissue sealing
US20070243130A1 (en) * 2006-04-18 2007-10-18 Weiliam Chen Biopolymer system for tissue sealing
US7854923B2 (en) * 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
US20090010982A1 (en) * 2006-04-18 2009-01-08 Endomedix, Inc. Biocompatible adherent sheet for tissue sealing
WO2008008857A2 (en) * 2006-07-11 2008-01-17 University Of Utah Research Foundation Thiolated macromolecules and methods of making and using thereof
BRPI0721211A2 (pt) * 2007-02-08 2013-01-15 Medtronic Xomed Inc uso de um tensoativo e um selante mÉdico, mÉtodo para tratar as condiÇÕes de ouvido, nariz e garganta, e, composiÇço
JP2009040697A (ja) * 2007-08-07 2009-02-26 Asuka Corporation:Kk 化粧料組成物
US20090062233A1 (en) * 2007-08-09 2009-03-05 Xin Ji Modified starch material of biocompatible hemostasis

Similar Documents

Publication Publication Date Title
WO2010050787A3 (ko) 스프레이 가능한 캡슐화된 기능성 미립자 조성물 및 그 제조방법
JP2015518006A5 (cg-RX-API-DMAC10.html)
WO2011022199A3 (en) Multi-layer transdermal patch
JP2010528132A5 (cg-RX-API-DMAC10.html)
GB201020193D0 (en) Glucan compositions
WO2007056073A3 (en) Medical device with a coating comprising an active form and an inactive form of therapeutic agent(s)
BR112018010234A2 (pt) spray formador de película tópica
WO2009140018A3 (en) Microencapsulated delivery system
MX340962B (es) Agentes de enlace a receptor de canabinoide, composiciones y metodos.
CL2018000033A1 (es) Composición para destapar una nariz tapada que tiene actividad antiviral.
JP2012525474A5 (cg-RX-API-DMAC10.html)
HK1247843A1 (zh) 具有受控吸收曲线的用於口服给药活性剂的制剂
WO2012087823A3 (en) Ph-induced silk fibroin gels and uses thereof
EP3106206A3 (en) Body ink compositions and applicators
BRPI1015447A8 (pt) Soluções pediátricas compreendendo um bloqueador beta
PE20171788A1 (es) Encapsulado de agentes activos de alta potencia
MX2015015589A (es) Composiciones y metodos para el suministro de agentes activos hidrófobos.
EP3575314A3 (en) Glucagon derivatives
EA201170117A1 (ru) Противоаллергические биополимеры морского происхождения
MX2017009699A (es) Composicion de suspension oftalmica.
WO2010018559A3 (en) Formulations for a two-phase management of wound healing and dressings incorporating such formulations.
BR112016017897A8 (pt) uso de composto de carboxamida heterocíclica de diamino no tratamento de câncer relacionado ao axl, composição farmacêutica e combinação
BRPI1006263A2 (pt) ''abosorvente interno''
JP2017535592A5 (cg-RX-API-DMAC10.html)
AR064954A1 (es) Composicion y metodo para estabilizar ingredientes sensibles